Zobrazeno 1 - 10
of 17
pro vyhledávání: '"van Acker FA"'
Publikováno v:
de Groot, M J, Bijlo, G J, Martens, B J, Goeptar, A R & Vermeulen, N P E 1997, ' A refined substrate model for human cytochrome P450 2D6. ', SON Discussiegroep Farmacochemie, Lunteren, 14/04/97-15/04/97 .
SON Discussiegroep Farmacochemie, Lunteren
Chemical Research in Toxicology, 10, 41-48. American Chemical Society
de Groot, M J, Bijlo, G J, Martens, B J, van Acker, F A A & Vermeulen, N P E 1997, ' A refined substrate model for human cytochrome P450 2D6. ', Chemical Research in Toxicology, vol. 10, pp. 41-48 . https://doi.org/10.1021/tx960129f
Vrije Universiteit Amsterdam
SON Discussiegroep Farmacochemie, Lunteren
Chemical Research in Toxicology, 10, 41-48. American Chemical Society
de Groot, M J, Bijlo, G J, Martens, B J, van Acker, F A A & Vermeulen, N P E 1997, ' A refined substrate model for human cytochrome P450 2D6. ', Chemical Research in Toxicology, vol. 10, pp. 41-48 . https://doi.org/10.1021/tx960129f
Vrije Universiteit Amsterdam
Cytochromes P450 (P450s) constitute a large superfamily of heme-containing enzymes, capable of oxidizing and reducing a variety of substrates. Cytochrome P450 2D6 is a polymorphic member of the P450 superfamily and is absent in 5-9% of the Caucasian
Publikováno v:
Chemical Research in Toxicology, 9, 1079-1091. American Chemical Society
de Groot, M J, Vermeulen, N P E, Kramers, J D, van Acker, F A A & Donné-Op den Kelder, G M 1996, ' A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108. ', Chemical Research in Toxicology, vol. 9, pp. 1079-1091 . https://doi.org/10.1021/tx960003i
de Groot, M J, Vermeulen, N P E, Kramers, J D, van Acker, F A A & Donné-Op den Kelder, G M 1996, ' A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108. ', Chemical Research in Toxicology, vol. 9, pp. 1079-1091 . https://doi.org/10.1021/tx960003i
Cytochromes P450 (P450s) constitute a superfamily of phase I enzymes capable of oxidizing and reducing various substrates. P450 2D6 is a polymorphic enzyme, which is absent in 5-9% of the Caucasian population as a result of a recessive inheritance of
Autor:
van Berlo D; Triskelion BV, Utrechtseweg 48, 3700 AV Zeist, The Netherlands. Electronic address: damien.vanberlo@triskelion.nl., Wallinga AE; Triskelion BV, Utrechtseweg 48, 3700 AV Zeist, The Netherlands. Electronic address: alinde.wallinga@triskelion.nl., van Acker FA; Triskelion BV, Utrechtseweg 48, 3700 AV Zeist, The Netherlands. Electronic address: frederique.vanacker@triskelion.nl., Delsing DJ; FrieslandCampina, Amersfoort, The Netherlands. Electronic address: dianne.delsing@frieslandcampina.com.
Publikováno v:
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association [Food Chem Toxicol] 2018 Aug; Vol. 118, pp. 84-93. Date of Electronic Publication: 2018 Apr 25.
Autor:
Dorn SB; Institut für Arbeitsphysiologie an der Universität Dortmund (IfADo), Ardeystrasse 67, Dortmund, Germany., Degen GH, Bolt HM, van der Louw J, van Acker FA, van den Dobbelsteen DJ, Lommerse JP
Publikováno v:
Archives of toxicology [Arch Toxicol] 2008 May; Vol. 82 (5), pp. 333-8. Date of Electronic Publication: 2007 Nov 09.
Autor:
Dorn SB; Institut für Arbeitsphysiologie an der Universität Dortmund, Ardeystr. 67, D-44139 Dortmund, Germany., Degen GH, Müller T, Bonacker D, Joosten HF, van der Louw J, van Acker FA, Bolt HM
Publikováno v:
Mutation research [Mutat Res] 2007 Apr 02; Vol. 628 (2), pp. 67-75. Date of Electronic Publication: 2007 Jan 14.
Autor:
Joosten HF; Department of Toxicology and Drug Disposition, Organon, P.O. Box 20, 5340 BH Oss, The Netherlands. Harrie.Joosten@Organon.com, van Acker FA, van den Dobbelsteen DJ, Horbach GJ, Krajnc EI
Publikováno v:
Toxicology letters [Toxicol Lett] 2004 Jun 15; Vol. 151 (1), pp. 113-34.
Autor:
van Acker FA; Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands. f.vanacker@azvu.nl, Hulshof JW, Haenen GR, Menge WM, van der Vijgh WJ, Bast A
Publikováno v:
Free radical biology & medicine [Free Radic Biol Med] 2001 Jul 01; Vol. 31 (1), pp. 31-7.
Autor:
van Acker FA; Department of Medical Oncology, University Hospital Vrije Universiteit, 1081 HV Amsterdam, The Netherlands. f.vanacker@azvu.nl, Boven E, Kramer K, Haenen GR, Bast A, van der Vijgh WJ
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2001 May; Vol. 7 (5), pp. 1378-84.
Autor:
Heijnen CG; Department of Pharmacology and Toxicology, Faculty of Medicine, Universiteit Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands. c.heijnen@farmaco.unimaas.nl, Haenen GR, van Acker FA, van der Vijgh WJ, Bast A
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2001 Feb; Vol. 15 (1), pp. 3-6.
Autor:
van Acker FA; Department of Medical Oncology, University Hospital Vrije Universiteit, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. f.vanacker@azvu.nl, van Acker SA, Haenen GR, Bast A, van der Vijgh WJ
Publikováno v:
Anticancer research [Anticancer Res] 2000 Nov-Dec; Vol. 20 (6B), pp. 4483-7.